#Cetas Healthcare

[cetas-healthcare]

The Evolution of Key Opinion Leader (KOL) Engagement: Embracing Digital Opinion Leaders (DOLs) in Healthcare

The landscape of healthcare influence is rapidly changing, marked by the significant shift from traditional Key Opinion Leader (KOL) engagement to the burgeoning role of Digital Opinion Leaders (DOLs). These are healthcare professionals who utilize digital and social media platforms to amplify their voice and expertise. This transition is a testament to the digital transformation within the healthcare industry, broadening the horizon of engagement and outreach. This blog explores the evolution of KOL engagement, the emergence of DOLs, and their growing impact on healthcare communication and decision-making.

From KOLs to DOLs: A Digital Transformation

Traditionally, KOL engagement in healthcare was characterized by face-to-face interactions, such as conferences, seminars, and advisory board meetings. KOLs, with their deep domain expertise, played a pivotal role in influencing clinical practices, research directions, and healthcare policies through direct, personal communication channels. However, the advent of digital technology has ushered in a new era of influencers known as Digital Opinion Leaders (DOLs).

DOLs harness the power of digital platforms, including social media, blogs, podcasts, and online forums, to disseminate their insights and engage with a broader audience. Unlike traditional KOLs, whose influence was often confined to academic or clinical settings, DOLs enjoy a far-reaching impact, capable of engaging with healthcare professionals, patients, and the general public across the globe.

The Strategic Importance of DOL Engagement

The rise of DOLs presents new opportunities and challenges for healthcare organizations. DOL engagement strategies include:

Expanding Reach and Accessibility: DOLs can communicate with vast audiences worldwide, breaking down geographical barriers and making it easier for healthcare professionals and patients to access valuable insights.

Enhancing Patient Engagement: Direct interaction with patients through digital platforms allows DOLs to offer guidance, answer questions, and demystify complex medical information.

Leveraging Diverse Platforms: DOLs operate across various digital channels, enabling them to tailor their messaging and content to suit different audiences and objectives.

Integrating DOLs into Healthcare Strategies

To leverage the influence of DOLs effectively, healthcare organizations must adapt their engagement strategies to the digital landscape. This involves identifying and collaborating with DOLs who align with their mission and values, creating high-quality, relevant content for distribution across digital channels, and employing analytics tools to measure the impact and refine strategies accordingly.

The Future: A Hybrid Model of Influence

Looking ahead, a hybrid model that incorporates both traditional KOL and digital DOL engagements appears to be the most effective approach. This model allows for the depth and credibility of established KOLs to blend with the reach and dynamism of DOLs, offering a comprehensive strategy to influence healthcare practices and patient outcomes positively.

Conclusion: Navigating the Digital Shift with Cetas Healthcare

As the healthcare industry embraces the digital age, Cetas Healthcare stands ready to guide organizations through this transformative journey. With specialized services designed to optimize both KOL and DOL engagements, Cetas Healthcare helps clients harness the collective power of these influencers to drive innovation, enhance patient care, and navigate the complexities of the digital healthcare landscape. Explore the possibilities of digital influence with Cetas Healthcare at Cetas Healthcare Key Opinion Leaders Expert Network.

The evolution from KOLs to DOLs reflects the broader digital transformation within healthcare, emphasizing the need for adaptive, forward-thinking engagement strategies. By embracing the unique strengths of both KOLs and DOLs, healthcare organizations can ensure they remain at the cutting edge of medical innovation and patient engagement.

[wiadomosciprasowe]

Cardiaccs appoints Shane West as CEO

https://www.y6.no/cardiaccs-appoints-shane-west-as-ceo/

Cardiaccs appoints Shane West as CEO

Mr. Shane West Dato: 16-05-2018 07:00 CEST Opprinnelig tittel på pressemeldingen: Cardiaccs appoints Shane West as CEO Kategori: , Medisinsk forskning Nye produkter, tjenester Vitenskap, teknikk Entreprenørskap

Cardiaccs, a Norwegian company developing innovative technology for direct monitoring of cardiac function, is pleased to announce the appointment of Mr. Shane West as Chief Executive Officer effective May 1st. Shane succeeds Prof. Erik Fosse who has been CEO since founding the company in 2009. Erik will continue to play a very active role in the company as Chairman of the Board of Directors.

Cardiaccs was founded in 2009 as a result of 8 years of research and development by the  Intervention Centre at Oslo University Hospital in cooperation with Buskerud and Vestfold University College. In 2014, the company was granted funding by the Research Council of Norway through the FORNY2020 program to commercialize the Cardisense sensor technology. The appointment of Mr. Shane West will strengthen Cardiaccs ability to achieve regulatory approval and commercialise CardiSense with an increased focus on market and customer strategy.

Shane brings more than 15 years of global MedTech experience to Cardiaccs. He led the Customer and Market Insight function for the global GE Healthcare portfolio, where he helped drive customer-centric approaches to product and service development. Since leaving GE Healthcare at the end of 2016, Shane has focused his attention on supporting Norwegian startups and global MedTech leaders with customer and market insights through his VP of Client Relations EMEA position at  Cetas Healthcare. Shane will continue in his role at Cetas Healthcare while taking on the role of CEO at Cardiaccs.

“Having come to know the CardiSense technology over the past 6 months I’m excited to be chosen to lead the company into its next exciting phase of commercialization,” said Shane West. “After listening to many physicians across the US and EU I’m convinced that CardiSense will be a valuable and sought-after monitoring tool for cardiac specialists”.

Shane has a BSc(Hons) in Cognitive Science and MBA from La Trobe University, Melbourne.

For more information please contact Cardiaccs via info@cardiaccs.com or:

Cardiaccs AS Gaustadalléen 21 0349 Oslo Norway

www.cardiaccs.com

Kilde: Pressekontor Aleap – PRESSEMELDING –

————

Non-profitt Inkubatoren Aleap er Norges største innovasjons og oppstarts miljø for gründere innen helse.Vårt mål er å forandre verden gjennom innovasjon, ved å utvikle et økosystem for oppstartsbedrifter innen helse, som gir ambisiøse entreprenører muligheten til å skape nye produkter og selskaper, bedre og raskere.

Vi gjør dette ved å tilby et bredt utvalg med viktig kunnskap og ekspertise, fleksibel infrastruktur og et internasjonalt forretningsnettverk. Vi mener at entreprenørskap og suksessfulle oppstartsselskap vil ha fordeler av å samarbeide i et tverrfaglig miljø hvor det å dele kunnskap er fundamentalt.

Hashtags: # #Medisinsk forskning Nye produkter, tjenester Vitenskap, teknikk Entreprenørskap Medisinsk forskning Nye produkter, tjenester Vitenskap, teknikk Entreprenørskap

[futuremarket]

Big Data Security Market Research Data Trends Upcoming Trends, Growth Drivers and Challenges, Forecast to 2025 (SARS-CoV-2, Covid-19 Analysis)

Big Data Security Market Research 

A new market study, titled “Big Data Security Market Research ” has been featured on Market Research Future.

Big data security market is rapidly strengthening its market position by infiltrating diverse sectors with the help of digitalization. Cyber attacks have become more intense and severe, spurring the demand for big data security. The global big data security market is expecting to take a leap from its current market valuation of USD 14 bn with a 16.9% CAGR during the forecast period (2017-2023), predicts Market Research Future (MRFR). The extensive study further incorporates drivers that can make the market more intense such as the growing demand for data mining and analytics, need for security integration, and on-cloud deployment. Big data security service further includes encryption, data masking, access control, security intelligence, data governance, and others. Its growing popularity in sectors such as banking, financial services and insurance (BFSI) travel & logistics, healthcare, government, automotive, and IT & telecommunication can be seen as a decisive factor for the big data security market in coming years. 

FREE PDF@ https://www.marketresearchfuture.com/sample_request/4410

However, lack of data security awareness can dampen the market prospect of the big data security market. But emergence and inclusion of third party service provider can take the market to an altogether new direction steering it away from the momentary hiccups during the forecast period.

Segmentation:

The global big data security market can be segmented by technology, component, deployment, organization size, and end-user. 

By technology, the big data security market can be segmented into identity & access management, security information & event management, unified threat management, and intrusion detection system/ intrusion prevention system. 

Based on component, the big data security market can be segmented into software and services.

By deployment, the big data security market can be segmented into on-cloud & on-premises.  

Based on organization size, the big data security market includes small & medium enterprises (SMEs), and large enterprises. 

Based on end-user, the big data security market can be segmented into BFSI, travel & logistics, healthcare, government, automotive, and IT & telecommunication. 

Regional Analysis:

Region-specific analysis of the big data security market includes North America, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW).

North America is leading the market with the maximum revenue share. The market is basking in the infrastructural superiority that the latest technological implementations provide. Furthermore, the region’s tendency to adopt the innovations into system is far greater than its peers which has ensured a favorable market ambience for the big data security market. The U.S. in the region is a substantial contributor and has contributed USD 3.45 billion in 2017. In addition, several market leaders are based out of this region.

The APAC is all set to score the fastest CAGR during the forecast period. With emerging economies such as India and China, exponential growth of this market has become only a matter of time. Furthermore, the market is getting tractioned by cost-effective advanced analytical software solutions and SMEs who are in need for high-security solutions. 

Market Insight:

The global big data security market is expecting strategic moves from the major market influencers which can take their market ahead. These tactical moves include merger, acquisition, and other methods which help the companies in taking steps as per their assessment of the competitive landscape.

IBM took over Vivisimo, a data discovery and navigation firm in 2018 to improve their market position. It is also buying Red Hat, a major distributor of open-source software and technology. 

VMware, in 2018, has acquired Cetas Software, a startup company with a focus on cloud data analytics. VMware is planning to reshape the enterprise data technologies. 

Symantec Corporation, in 2018, bought Blue Coat, a leading company that provides security to market behemoths and governments.  

Eminent market players involved in this big data security market are IBM, Hewlett Packard Enterprise (HPE), Symantec Corporation, Fortinet, Check Point Software Technologies Ltd. FireEye Inc., Rapid7 Inc., Proofpoint Inc., LogRhythm Inc., and others.

More Information@ https://www.marketresearchfuture.com/reports/big-data-security-market-4410

About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research and Consulting Services. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com

[allthecanadianpolitics]

Could you describe me a neo liberal? Please? I'm kinda confused on the meaning and if Trudeau is one

Here’s a definition:

Neoliberalism is a policy model of social studies and economics that transfers control of economic factors to the private sector from the public sector. It takes from the basic principles of neoclassical economics, suggesting that governments must limit subsidies, make reforms to tax law in order to expand the tax base, reduce deficit spending, limit protectionism, and open markets up to trade. It also seeks to abolish fixed exchange rates, back deregulation, permit private property, and privatize businesses run by the state.

Justin Trudeau is a Neoliberal.

-He’s considering selling Canada’s airports & ports to the private sector:

Liberal Flirtation With Privatizing Airports Sets Off Alarm Bells

Privatizing Canada’s airports would bring costs for travellers and profits for corporations

-Is running an infrastructure bank which will likely lead to privatization of infrastructure:

Opinion: Trump and Trudeau plan to sell out our public infrastructure

Trump and Trudeau are gunning to massively privatize infrastructure – and it’s going to cost you - Behind the Numbers

Without any mandate, Trudeau pushes privatization

Liberals redirect $15B to infrastructure projects that ‘generate revenue’ for private investors

Some more links on Justin Trudeau’s Neoliberalism:

Trudeau’s criticism of ‘corporate elites’ rings hollow

Millions promised for Indigenous kids is subsidizing mining companies, internal documents show

If Trudeau Really Blames Corporate Elites, Why Did He Sign CETA?

Don’t be fooled by 'good-looking Liberals:’ Fonda on Trudeau’s climate action

Bay Street pressured Liberals to break promise to close CEO tax loophole, documents show

How Trudeau Is Screwing Over the Generation That Got Him Elected

Justin Trudeau’s giant corporate giveaway | Martin Lukacs

Trudeau cabinet approves Trans Mountain, Line 3 pipelines, rejects Northern Gateway

Canada could face ’20 Standing Rocks,’ says Mohawk chief as Ottawa rejects need for ‘consent’

Justin Trudeau is also keeping Stephen Harper’s weak climate change targets (and has seemingly no way of meeting these targets with all his pipeline approvals). He’s also keeping Stephen Harper’s cuts to healthcare transfers. He’s rejected calls to improve Canada’s healthcare system by covering prescription medication.

[thelibertybeaconproject-blog]

Is the unelected EU Commission preparing a new privatisation push?

Is the European Commission preparing a new privatisation push? CORPORATE EUROPE OBSERVATORY Concerns have been aroused that a new wave of privatisation could be prepared after the European Commission asked KPMG to study the “operational and fiscal challenges” which state-owned enterprises place on the public purse. The contract, due to conclude at the end of this month, raises many questions.

[supersanuse]

Global Leak Test Equipment Market

Global Leak Test Equipment Market was valued US$ 4.62  Bn in 2018 and expected to reach US$ XX Bn by 2026, at a CAGR of XX % during forecast period. Global Leak test equipment market is segmented into components, equipment type, end-use industry, and region. On the basis of components, market is divided into hardware, software, and services. Based on equipment type, market is segmented by portable, and fixed. For end-use industry market is classified into HVAC/R, Automotive & Transportation, Medical & Pharmaceutical, Packaging, Industrial, Others. Geographically market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Increasing incidents of oil & gas leakages in pipelines and storage tanks at production facilities, strict government regulations pertaining to the implementation of leak test equipment. The leak testing equipment is used to detect manufacturing defects which helps verifying the integrity of products and also improves consumer safety. The use of leak testing equipment allows to know the escape of liquids, vacuum, or gases from sealed components or systems. At the same time entry of new start-ups in the market are limiting the growth of leak test equipment market. In terms of components, the services segment is anticipated to surpass US$ 260 Mn, in terms of revenue, by 2026. The calibration sub-segment of the services segment is anticipated to expand at a significant CAGR of more than 9% during the forecast period.

The leak test equipment must be calibrated, as it helps in determining the rate of leakage. Based on equipment type, the portable equipment type segment is anticipated to hold a higher share of the market share, owing to the rising demand for portable leak test equipment. The portable leak test equipment can be used for leak detection both, on-site, i.e., on the premises of the company, and across a variety of remote locations around the globe. In terms of region, North America is expected to hold a major share of the leak test equipment market during the forecast period. It is home to several well-established players from the leak test equipment market, North America is witnessing a higher rate of implementation of leak test equipment owing to the consistent expansion of the automotive industry in the region. Key players operated in leak test equipment market are Inficon, ATEQ Corp, LACO Technologies, Pfeiffer Vacuum GmbH , Ceta Testsysteme GmbH , Cosmo Instruments Co., ltd., InterTech Development Company, Uson, L.P, Vacuum Instruments Corporation, LLC, TASI Group, Tecna srl, CETA, Changzhou Changce, Kane International, Rothenberger, HAIRUISI, Hermann Sewerin, Cosmo Instruments, VIC Leak Detection.

The objective of the report is to present comprehensive analysis of Global Leak Test Equipment Market, by geography for automotive including all the stakeholders of the industry. The past and current status of the industry with forecasted Market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes Market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the Market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Leak Test Equipment Market, by geography for automotive dynamics, structure by analyzing the Market segments, and project the Global Leak Test Equipment Market, by geography for automotive size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Leak Test Equipment Market, by geography for automotive the report investor’s guide.

The Scope of Global Leak Test Equipment Market:Global Leak Test Equipment Market, by components

• Hardware

• Software

• Services

Global Leak Test Equipment Market, by Equipment type

• Portable • Fixed

Global Leak Test Equipment Market, by End-Use Industry

• Industrial

• Automotive

• Medical

• HVAC/R

• Laboratories

• Energy

Global Leak Test Equipment Market, by Region

• North America

• Asia-Pacific

• Europe

• Latin America

• Middle East & Africa

Key players operated in Global Leak Test Equipment Market:

• Inficon

• ATEQ Corp

• LACO Technologies

• Pfeiffer Vacuum GmbH

• Ceta Testsysteme GmbH

• Cosmo Instruments Co., ltd.

• InterTech Development Company

• Uson, L.P

• Vacuum Instruments Corporation, LLC

• TASI Group

• Tecna srl

• CETA

• Changzhou • Changce

• Kane International

• Rothenberger

• HAIRUISI

• Hermann Sewerin

• Cosmo Instruments

• VIC Leak Detection.

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact Us:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH

Email: sales@maximizemarketresearch.com

Contact:  +91 9607365656

[prooftheword]

Top-Notch Editing Service

“Once again, Sara provided good and timely services. I recommend her for proofreading projects.” – Dushyant Gupta, Bangalore, India (Cetas Healthcare) [proofread & edited business plan, April 2018

Here is feedback I had from a very happy client last year. I edited Cetas Healthcare’s business proposal for opening a new office in the US, and they were very happy with the work I did for them.

If…

[cetas-healthcare]

Assessing the Impact of a New DXA Concept in the Medical Technology Sphere

Introduction:

Conducted at Cetas Healthcare, this case study explores a global medical technology company's venture to test the value proposition of a new Dual-energy X-ray Absorptiometry (DXA) concept. It underscores the company's efforts to gauge stakeholder perception, concept preference, and messaging effectiveness within the medical community.

Introduction to the Client

A global medical technology company, renowned for developing a wide array of medical devices and technologies, embarked on a journey to introduce a new Dual-energy X-ray Absorptiometry (DXA) solution to the market.

The Challenge: Launching a New DXA Solution

The company faced the challenge of determining:

Which among their three proposed DXA concepts would most effectively resonate with stakeholders.

What specific messages would appeal to particular stakeholder groups.

Research Methodology: Deep-Dive into Stakeholder Perceptions

Approach

A series of 60-minute in-depth telephonic interviews were conducted with key professionals, including Radiologists, Radiology Administrators, Endocrinologists, and Rheumatologists.

Objectives of the Research

The study aimed to:

Understand current dynamics and unmet needs in DXA system usage.

Evaluate current brand usage, satisfaction, differentiators, and challenges in DXA.

Test the value proposition and messaging of the three new DXA concept versions.

Explore the willingness to pay for additional features, preferred payment models, and identify key stakeholders in the DXA system purchasing process.

Insights and Strategic Outcomes

Key Findings

Gained insights into the current DXA market, including system usage, challenges faced, brand preferences, and differentiators.

Assessed stakeholder perceptions of the new DXA concepts, identifying most and least favored attributes, preferred concept among the three versions, and favored payment models.

Evaluated responses to various messages, likelihood of adoption, and reasons for these preferences.

Explored preferences for additional features and stakeholders' willingness to pay for these enhancements.

Identified key decision-makers involved in purchasing DXA systems.

Client Benefit

With these insights, the client gained a comprehensive understanding of the current DXA landscape. This knowledge empowered them to make informed decisions about introducing their new concept into the existing market, aligning their strategies with stakeholder needs and preferences.

Conclusion: Navigating the DXA Market with Informed Strategies

This research provided the client with crucial data to tailor their new DXA concept effectively, ensuring it meets market demands and resonates with key stakeholders, thereby enhancing the potential for successful market penetration and adoption.

[healthcare366-blog]

Biological Safety Cabinet Market by Type & End User - 2022 | MarketsandMarkets

The biological safety cabinets market was valued at USD 137.5 Million in 2016 and is projected to reach USD 205.9 Million by 2022 at a CAGR of 7.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Objectives of the Study

To define, describe, and forecast the global biological safety cabinets market by type, end user, and region

To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

To analyze micromarkets with respect to indivi dual growth trends, prospects, and contributions to the overall market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast size of market segments with respect to the four key regions - North America, Europe, Asia Pacific, and RoW

To analyze the market structure and profile key players of the global biological safety cabinets market and comprehensively analyze their core competencies

To analyze the competitive landscape of the major players operating in the biological safety cabinets market

To Know More @ https://www.marketsandmarkets.com/Market-Reports/biological-safety-cabinet-market-60228904.html

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid (CSF) management market and estimate the size of other dependent submarkets. Various secondary sources such as American Biological Safety Association (ABSA), International Federation of Biosafety Associations (IFBA), International Society of Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Society for In Vitro Biology (SIVB), Controlled Environment Testing Association (CETA), Asia Pacific Biosafety Association (APBA), Canadian Association for Biological Safety (CABS-ACSB), Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as

well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The major market players in the biological safety cabinets market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco Corporation (US), The Baker Company (US), Kewaunee Scientific Corporation (US), NuAire (US), Germfree Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science LLC (US), Berner International (Germany), and BIOBASE (China).

Target Audience:

Government and private research institutes

Manufacturers and suppliers of biological safety cabinets

Pharmaceutical and biopharmaceutical companies

Academic and research institutes

Venture capitalists

Medical research centers

Research and consulting firms

Scope of the Report:

[Healthcare IT Market Research Reports & Consulting ]Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model - GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

[futuremarket]

Big Data Security Market Trends to Clock a CAGR of 16.9% in Between 2017 and 2023: Predicts MRFR

Big Data Security Market Trends

Big data security market is rapidly strengthening its market position by infiltrating diverse sectors with the help of digitalization. Cyber attacks have become more intense and severe, spurring the demand for big data security. The global big data security market is expecting to take a leap from its current market valuation of USD 14 bn with a 16.9% CAGR during the forecast period (2017–2023), predicts Market Research Future (MRFR). The extensive study further incorporates drivers that can make the market more intense such as the growing demand for data mining and analytics, need for security integration, and on-cloud deployment. Big data security service further includes encryption, data masking, access control, security intelligence, data governance, and others. Its growing popularity in sectors such as banking, financial services and insurance (BFSI) travel & logistics, healthcare, government, automotive, and IT & telecommunication can be seen as a decisive factor for the big data security market in coming years.

However, lack of data security awareness can dampen the market prospect of the big data security market. But emergence and inclusion of third party service provider can take the market to an altogether new direction steering it away from the momentary hiccups during the forecast period.

Segmentation:

The global big data security market can be segmented by technology, component, deployment, organization size, and end-user.

By technology, the big data security market can be segmented into identity & access management, security information & event management, unified threat management, and intrusion detection system/ intrusion prevention system.

Based on component, the big data security market can be segmented into software and services.

By deployment, the big data security market can be segmented into on-cloud & on-premises.

Based on organization size, the big data security market includes small & medium enterprises (SMEs), and large enterprises.

Based on end-user, the big data security market can be segmented into BFSI, travel & logistics, healthcare, government, automotive, and IT & telecommunication.

Regional Analysis:

Region-specific analysis of the big data security market includes North America, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW).

North America is leading the market with the maximum revenue share. The market is basking in the infrastructural superiority that the latest technological implementations provide. Furthermore, the region’s tendency to adopt the innovations into system is far greater than its peers which has ensured a favorable market ambience for the big data security market. The U.S. in the region is a substantial contributor and has contributed USD 3.45 billion in 2017. In addition, several market leaders are based out of this region.

The APAC is all set to score the fastest CAGR during the forecast period. With emerging economies such as India and China, exponential growth of this market has become only a matter of time. Furthermore, the market is getting tractioned by cost-effective advanced analytical software solutions and SMEs who are in need for high-security solutions.

Market Insight:

The global big data security market is expecting strategic moves from the major market influencers which can take their market ahead. These tactical moves include merger, acquisition, and other methods which help the companies in taking steps as per their assessment of the competitive landscape.

IBM took over Vivisimo, a data discovery and navigation firm in 2018 to improve their market position. It is also buying Red Hat, a major distributor of open-source software and technology.

VMware, in 2018, has acquired Cetas Software, a startup company with a focus on cloud data analytics. VMware is planning to reshape the enterprise data technologies.

Symantec Corporation, in 2018, bought Blue Coat, a leading company that provides security to market behemoths and governments.

More Information@ https://www.marketresearchfuture.com/reports/big-data-security-market-4410

About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research and Consulting Services. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com

[healthcarebiz]

SGS Hong Kong and The Lab (Asia) Ltd. New Certification Capabilities on Medical Facilities

HONG KONG, June 22, 2017 /PRNewswire/ -- SGS Hong Kong and The Lab (Asia) Ltd (member of the SGS Group) are pleased to announce new services for Biosafety Cabinet Certification, Cleanroom Certification and Aseptic Medicine Compounding Process and Facilities Certification carried by The Lab (Asia). These services aim at safeguarding the operations from biocontamination in both public and private hospitals, overseas pharmaceutical companies and medical equipment manufacturers.

Our Special Projects Department specializes in performing gap analysis on doubtful facilities, primarily containment equipment, procedures and human error to prevent unwanted contamination and microbial infection to devoted hospital workers, dedicated research specialist and microbiological lab technicians, as well as critical patients fighting for lives.

As the only third party and independent company offering comprehensive certification services in Hong Kong and South East Asia, we play a critical role in ensuring the safety and credibility of healthcare, medical, pharmaceutical corporations and related educational and training entities in the region.

The globally recognized certificates are not only legitimate documents to comply with regulations from the Department of Health and respective authorities in Hong Kong and internationally, but a proactive precaution towards running these life-saving operations optimally via secure processes and procedures, day after day. Our in-house professionals are NSF, NEBB, CETA and HOKLAS accredited and our key clients include some leading education institutions in the city. 

Since 2015, a professional certificate in medical device regulatory affairs and quality assurance program has been launched by SGS Hong Kong, in collaboration with leading regulatory specialist. 

SGS have also been undertaking tests for medical device packaging and hosting regular seminars on industry updates. The new services are the result of the enhanced capabilities under the co-branding effort of SGS Hong Kong and The Lab (Asia) Ltd. In addition to the certification services for the healthcare industry, The Lab (Asia) is also serving the construction, civil engineering, highways, airports and associated industries.

SGS Hong Kong and The Lab (Asia) Ltd. New Certification Capabilities on Medical Facilities

ABOUT The Lab (Asia) and SGS

The Lab (Asia) Ltd is a member of the SGS Group, combining global strengths and local expertise to deliver materials testing, inspection and consulting serving the construction, civil engineering, highways, airports and associated industries. This new capability has been developed to expanded solutions for medical and healthcare facilities. Web site: http://www.thelab.asia

The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognized as the global benchmark in quality and integrity. With more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world. Web site: www.sgsgroup.com

Contacts Ms. Cybil Law, Cybil.Law@sgs.com, +852 2774 7478

For further information, please contact:

Ir Donney Leung, Biosafety Consultant Address:  22 San Hi Tsuen Street, Ping Shan, Yuen Long, N.T. Hong Kong Tel :+852 2146 0535 / +852 9098 3164, E-mail: Donney@thelab.asia   Web site: http://www.thelab.asia

SGS Hong Kong and The Lab (Asia) Ltd. New Certification Capabilities on Medical Facilities

  Photo - http://ift.tt/2sXrOMd Photo - http://ift.tt/2rELEaS

Read this news on PR Newswire Asia website: SGS Hong Kong and The Lab (Asia) Ltd. New Certification Capabilities on Medical Facilities

[aneddoticamagazinestuff]

Mortalità evitabile

New Post has been published on https://www.aneddoticamagazine.com/it/mortalita-evitabile/

Mortalità evitabile

Negli USA, la terza causa di morte non naturale sono gli errori medici. Ad affermarlo è uno studio pubblicato sul British Medical Journal: diagnosi sbagliate, incapacità del personale sanitario e mancanza di comunicazione sarebbero la causa di circa 251mila decessi, la terza causa di morte, dopo le malattie cardiovascolari 611mila e il (cancro 585mila) e prima delle malattie respiratorie. I ricercatori hanno basato la propria analisi sui dati dei pazienti dal 2000 al 2008. una cifra spaventosa se si pensa che si tratta del 9,5% del totale dei decessi negli Usa in un anno. Se ci si riferisce ai ricoveri ospedalieri, una percentuale tra lo 0,4 e l’1,1 per cento dei pazienti che entrano in un ospedale non ne uscirebbe più a causa di uno sbaglio.

Si tratta di numeri considerevoli ma dei quali nessuno parla. Secondo Martin Makary e Michael Daniel, della Johns Hopkins University School of Medicine di Baltimora, ciò potrebbe essere dovuto al fatto che nei certificati di morte da compilare negli Stati Uniti alla dipartita del paziente l’errore umano non è previsto. E quindi non segnalato. “L’errore umano è inevitabile” scrivono Makary e Daniel.

Un’accusa gravissima che non poteva non avere conseguenze rilevanti e razioni diverse. Da un lato c’è chi sostiene che si tratti di un errore e riporta altre graduatorie come quella che vede al terzo posto delle cause di morte negli USA le malattie respiratorie croniche (e poi gli incidenti, le malattie cerebrovascolari, l’Alzheimer, il diabete, l’influenza e le complicazioni polmonari etc). Dall’altro che si tratta di un problema serio lo si sapeva da tempo: uno studio dell’Institute of Medicine (IOM) risalente al 1999 parlava di un numero di casi di morti dovute a errori medici tra i 44mila e i 98mila casi all’anno solo negli USA. Prima ancora, nel 1984, l’Harvard Medical Practice Study e nel 1993, Leape, capo ricercatore pubblicò uno studio in cui diceva che tra il 78% e il 51% of the 180 000 morti ospedaliere sarebbero state evitabili. Poi, nel 2004, fu un rapporto dell’Agenzia della Healthcare Quality and Research Patient Safety Indicators che parlò di ben 575mila morti causate da errori medici tra il 2000 e il 2002.

L’elenco degli studi che confermerebbero questa tesi è lunghissimo. Una conferma, se mai ce ne fosse bisogno, che sono molte, troppe le morti ospedaliere che potrebbero essere evitate.

E non solo negli USA. Anche in Europa. A confermarlo è uno studio molto più recente dell’Organizzazione Mondiale della Sanità che riporta che gli errori medici nelle strutture ospedaliere dei paesi dell’Unione sono una percentuale altissima: addirittura tra l’8 e il 12%. Dati confermati dallo studio An organisation with a memory dell’United Kingdom Department of Health, che parla di circa 850mila casi in un anno (riferiti al 2000), il 10% di tutti i ricoveri. Dati analoghi sono stati registrati anche in Spagna Francia e Danimarca.

Errori come le infezioni che riguardano annualmente un paziente ogni venti (circa 4.1 milioni di pazienti): infezioni delle vie urinarie (27%), delle vie respiratorie (24%), postoperatorie (17%) e legate alle trasfusioni (10.5%). Anche le infezioni fa Staphylococcus aureus multiresistente sono diffuse: riguardano circa il 5% di tutte le infezioni.

Secondo il rapporto della WHO il 23% dei cittadini europei afferma di essere stato vittima di errori medici, il 18% dice che questi errori erano gravi errori causati durante il ricovero in ospedale e l’11% denuncia errori nella prescrizione dei farmaci o delle cure. Secondo la WHO tra il 50% e il 70.2% di questi errori avrebbe potuto essere evitato con una maggiore attenzione e professionalità.

Errori che a volte causano anche la morte dei pazienti: sarebbero 95000 i casi di morti precoci a causate da questi “errori”. Ma a questi sarebbe giusto aggiungere i 260mila casi di disabilità permanente.

“Tumori e malattie cardiache ricevono tonnellate d’attenzione – ha detto Martin Makary, della Johns Hopkins – gli errori medici non figurano invece sulla lista” dei ‘big killer’. Sarebbe questo il motivo che limita le azioni in questo senso: a questo problema non vengono destinati “i fondi e l’attenzione che merita”. Per non parlare del fatto che spesso non si tratta di errori commessi dal personale medico: molto spesso la causa sono problemi sistematici o percorsi assicurativi frammentati (negli USA, ma visti i cambiamenti in corso anche in altri paesi) o la mancanza di protocolli adeguati.

Errori che hanno anche un altro effetto negativo: secondo l’analisi condotta dallo United Kingdom National Audit Office questi errori costano alla comunità circa un miliardo di sterline ogni anno.

E in Italia? Uno studio più del 2017 sulla “mortalità evitabile” (MEV), condotto dal gruppo di Nebo ricerche e basato su dati dell’Istat ed Eurostat, parla di 103mila le morti “evitabili avvenute entro i primi 75 anni di vita in Italia” su un totale di circa 600mila. In questo caso, però, questo numero non riporta solo errori medici ma in modo più ampio di stili di vita errati: vengono presi in considerazione i decessi che potevano essere rimandati grazie a interventi di prevenzione primaria (cioè seguendo le regole antinfortunistiche sul lavoro, oppure riducendo il fumo e il consumo di alcolici, facendo una dieta equilibrata e svolgendo attività fisica), ma anche con una diagnosi tempestiva e con il ricorso a cure appropriate (ad esempio screening e terapie oncologiche) e con un’assistenza adeguata (ad esempio quella ai malati cronici).

Related Post

MiNDS – Miniaturized Neural Drug Delivery Sy...

Il costo della vita negli anni ’30.

STOP CETA

ROMA ANTICA di Fulvio Marino

Conversation at the fourth floor II

Superstizioni e credenze popolari

Luc Descheemaeker: Trump…

Luc Descheemaeker: Freedom

Firenze: 3 e 4 agosto del 1944

Pete Kreiner: “Portrait of a Victim”

La storia del Gruppo Valanga. Battaglie, sacrifici...

Polar 4 expedition by World Arctic Fund

.yuzo_related_post imgwidth:155px !important; height:145px !important; .yuzo_related_post .relatedthumbline-height:15px;background: !important;color:!important; .yuzo_related_post .relatedthumb:hoverbackground:#fcfcf4 !important; -webkit-transition: background 0.2s linear; -moz-transition: background 0.2s linear; -o-transition: background 0.2s linear; transition: background 0.2s linear;;color:!important; .yuzo_related_post .relatedthumb acolor:!important; .yuzo_related_post .relatedthumb a:hover color:!important;} .yuzo_related_post .relatedthumb:hover a color:!important; .yuzo_related_post .yuzo_text color:!important; .yuzo_related_post .relatedthumb:hover .yuzo_text color:!important; .yuzo_related_post .relatedthumb margin: 0px 0px 0px 0px; padding: 5px 5px 5px 5px; jQuery(document).ready(function( $ ) //jQuery('.yuzo_related_post').equalizer( overflow : 'relatedthumb' ); jQuery('.yuzo_related_post .yuzo_wraps').equalizer( columns : '> div' ); )

[cetas-healthcare]

Latest Blog: Key Market Research Studies for MedTech Companies

Explore essential market research studies pivotal for new product development in the medical device industry, ensuring strategic success from ideation to commercialization. Dive into our detailed guide on market analysis, customer needs, regulatory compliance, and pricing strategies at Cetas Healthcare.

[cetas-healthcare]

In this case study at Cetas Healthcare, we examine the efforts of a global provider of medical technology to establish a baseline on brand health and communication impact in the diagnostic market.

[cetas-healthcare]

Market Opportunity Evaluation for CEM in Mammography

This case study at Cetas Healthcare focuses on a global medical technology company's initiative to understand the market potential for Contrast-Enhanced Mammography (CEM) in the US and Europe.